Preadolescent Methylphenidate versus Cocaine Treatment Differ in The Expression of Cocaine-Induced Locomotor Sensitization During Adolescence and Adulthood

Biological Psychiatry

Volumn 60, Issue 11, 2006, Pages 1171-1180

  Guerriero, Réjean M ^a,b   Hayes, Margaret M ^a,b,c   Dhaliwal, Sharon K ^a,b   Ren, Jia Qian ^a,b   Kosofsky, Barry E ^a,b,d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BOSTON COLLEGE   (United States)

^d NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

attention deficit hyperactivity disorder; brain development; cocaine; Locomotor sensitization; methylphenidate

Indexed keywords

COCAINE; METHYLPHENIDATE; SODIUM CHLORIDE;

ADAPTATION; ADOLESCENCE; ADOLESCENT; ADULTHOOD; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR DISORDER; COCAINE DEPENDENCE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DEPENDENCE; DRUG EFFECT; FEMALE; HYPERACTIVITY; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; TREATMENT DURATION; TREATMENT RESPONSE;

AGE FACTORS; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; BEHAVIOR, ANIMAL; COCAINE; COCAINE-RELATED DISORDERS; DISEASE MODELS, ANIMAL; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; LOCOMOTION; MALE; METHYLPHENIDATE; MICE; PREGNANCY; WEIGHT GAIN;

EID: 33750632481     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2006.03.034     Document Type: Article

References (72)

1. Achat-Mendes C., Anderson K.L., and Itzhak Y. Methylphenidate and MDMA adolescent exposure in mice: long-lasting consequences on cocaine-induced reward and psychomotor stimulation in adulthood. Neuropharmacology 45 (2003) 106-115
2. Andersen S.L., Arvanitogiannis A., Pliakas A.M., LeBlanc C., and Carlezon Jr. W.A. Altered responsiveness to cocaine in rats exposed to methylphenidate during development. Nat Neurosci 5 (2002) 13-14
3. Bergman J., Madras B.K., Johnson S.E., and Spealman R.D. Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys. J Pharmacol Exp Ther 251 (1989) 150-155
4. Berke J.D., and Hyman S.E. Addiction, dopamine, and the molecular mechanisms of memory. Neuron 25 (2000) 515-532
5. Bolanos C.A., Barrot M., Berton O., Wallace-Black D., and Nestler E.J. Methylphenidate treatment during pre- and periadolescence alters behavioral responses to emotional stimuli at adulthood. Biol Psychiatry 54 (2003) 1317-1329
6. Brandon C.L., Marinelli M., Baker L.K., and White F.J. Enhanced reactivity and vulnerability to cocaine following methylphenidate treatment in adolescent rats. Neuropsychopharmacology 25 (2001) 651-661
7. Brandon C.L., Marinelli M., and White F.J. Adolescent exposure to methylphenidate alters the activity of rat midbrain dopamine neurons. Biol Psychiatry 54 (2003) 1338-1344
8. Brunell S.C., and Spear L.P. Effects of ethanol and amphetamine on the acoustic startle response and prepulse inhibition in adolescent and adult rats (2004), Society For Neuroscience Abstracts, San Diego, CA
9. Carlezon Jr. W.A., and Konradi C. Understanding the neurobiological consequences of early exposure to psychotropic drugs: linking behavior with molecules. Neuropharmacology 47 Suppl 1 (2004) 47-60
10. Carlezon Jr. W.A., Mague S.D., and Andersen S.L. Enduring behavioral effects of early exposure to methylphenidate in rats. Biol Psychiatry 54 (2003) 1330-1337
11. Connor D.F. Preschool attention deficit hyperactivity disorder: a review of prevalence, diagnosis, neurobiology, and stimulant treatment. J Dev Behav Pediatr 23 1 Suppl (2002) S1-S9
12. Crawford C.A., McDougall S.A., Meier T.L., Collins R.L., and Watson J.B. Repeated methylphenidate treatment induces behavioral sensitization and decreases protein kinase A and dopamine-stimulated adenylyl cyclase activity in the dorsal striatum. Psychopharmacology (Berl) 136 (1998) 34-43
13. Crozatier C., Guerriero R.M., Mathieu F., Giros B., Nosten-Bertrand M., and Kosofsky B.E. Altered cocaine-induced behavioral sensitization in adult mice exposed to cocaine in utero. Brain Res Dev Brain Res 147 (2003) 97-105
14. Duckworth L., and Van Horn G. A Computational Investigation of the Structures and Properties of Derivatives of Methylphenidate and Cocaine with Comparisons to Experimental Activity Data (2002), University of Wisconsin-Whitewater, Whitewater, Wisconsin Proceedings of The National Conference on Undergraduate Research (NCUR)
15. Ehrlich M.E., Sommer J., Canas E., and Unterwald E.M. Periadolescent mice show enhanced DeltaFosB upregulation in response to cocaine and amphetamine. J Neurosci 22 (2002) 9155-9159
16. Fukui R., Svenningsson P., Matsuishi T., Higashi H., Nairn A.C., Greengard P., et al. Effect of methylphenidate on dopamine/DARPP signalling in adult, but not young, mice. J Neurochem 87 (2003) 1391-1401
17. Gainetdinov R.R., Wetsel W.C., Jones S.R., Levin E.D., Jaber M., and Caron M.G. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 283 (1999) 397-401
18. Gaytan O., al-Rahim S., Swann A., and Dafny N. Sensitization to locomotor effects of methylphenidate in the rat. Life Sci 61 (1997) PL101-PL107
19. Gerasimov M.R., and Dewey S.L. Gamma-vinyl gamma-aminobutyric acid attenuates the synergistic elevations of nucleus accumbens dopamine produced by a cocaine/heroin (speedball) challenge. Eur J Pharmacol 380 (1999) 1-4
20. Gerasimov M.R., Franceschi M., Volkow N.D., Gifford A., Gatley S.J., Marsteller D., et al. Comparison between intraperitoneal and oral methylphenidate administration: A microdialysis and locomotor activity study. J Pharmacol Exp Ther 295 (2000) 51-57
21. Gerasimov M.R., Franceschi M., Volkow N.D., Rice O., Schiffer W.K., and Dewey S.L. Synergistic interactions between nicotine and cocaine or methylphenidate depend on the dose of dopamine transporter inhibitor. Synapse 38 (2000) 432-437
22. Gerdeman G.L., Partridge J.G., Lupica C.R., and Lovinger D.M. It could be habit forming: drugs of abuse and striatal synaptic plasticity. Trends Neurosci 26 (2003) 184-192
23. Goldman L.S., Genel M., Bezman R.J., and Slanetz P.J. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association. JAMA 279 (1998) 1100-1107
24. Guerriero R.M., Rajadhyaksha A., Crozatier C., Giros B., Nosten-Bertrand M., and Kosofsky B.E. Augmented constitutive CREB expression in the nucleus accumbens may contribute to the altered behavioral response to cocaine of adult mice exposed to cocaine in utero. Dev Neurosci 27 (2005) 235-248
25. Hyman S.E., and Nestler E.J. Initiation and adaptation: a paradigm for understanding psychotropic drug action. Am J Psychiatry 153 (1996) 151-162
26. Izenwasser S., Coy A.E., Ladenheim B., Loeloff R.J., Cadet J.L., and French D. Chronic methylphenidate alters locomotor activity and dopamine transporters differently from cocaine. Eur J Pharmacol 373 (1999) 187-193
27. Johanson C.E., and Schuster C.R. A choice procedure for drug reinforcers: cocaine and methylphenidate in the rhesus monkey. J Pharmacol Exp Ther 193 (1975) 676-688
28. Kalivas P.W., and Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Brain Res Rev 16 (1991) 223-244
29. Koob G.F. Cocaine reward and dopamine receptors: love at first site. Arch Gen Psychiatry 56 (1999) 1107-1108
30. Kuczenski R., and Segal D.S. Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine. J Neurochem 68 (1997) 2032-2037
31. Kuczenski R., and Segal D.S. Locomotor effects of acute and repeated threshold doses of amphetamine and methylphenidate: relative roles of dopamine and norepinephrine. J Pharmacol Exp Ther 296 (2001) 876-883
32. Lin S.N., Andrenyak D.M., Moody D.E., and Foltz R.L. Enantioselective gas chromatography-negative ion chemical ionization mass spectrometry for methylphenidate in human plasma. J Anal Toxicol 23 (1999) 524-530
33. Madras B.K., Fahey M.A., Bergman J., Canfield D.R., and Spealman R.D. Effects of cocaine and related drugs in nonhuman primates. I. [3H]cocaine binding sites in caudate-putamen. J Pharmacol Exp Ther 251 (1989) 131-141
34. Mague S.D., Andersen S.L., and Carlezon Jr. W.A. Early developmental exposure to methylphenidate reduces cocaine-induced potentiation of brain stimulation reward in rats. Biol Psychiatry 57 (2005) 120-125
35. McNamara C.G., Davidson E.S., and Schenk S. A comparison of the motor-activating effects of acute and chronic exposure to amphetamine and methylphenidate. Pharmacol Biochem Behav 45 (1993) 729-732
36. Meririnne E., Kankaanpaa A., and Seppala T. Rewarding properties of methylphenidate: sensitization by prior exposure to the drug and effects of dopamine D1- and D2-receptor antagonists. J Pharmacol Exp Ther 298 (2001) 539-550
37. Nestler E.J. Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2 (2001) 119-128
38. Nestler E.J. Molecular neurobiology of addiction. Am J Addict 10 (2001) 201-217
39. Pierce R.C., and Kalivas P.W. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Brain Res Rev 25 (1997) 192-216
40. Post R.M., and Rose H. Increasing effects of repetitive cocaine administration in the rat. Nature 260 (1976) 731-732
41. Reid M.S., Mickalian J.D., Delucchi K.L., Hall S.M., and Berger S.P. An acute dose of nicotine enhances cue-induced cocaine craving. Drug Alcohol Depend 49 (1998) 95-104
42. Ritz M.C., Lamb R.J., Goldberg S.R., and Kuhar M.J. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237 (1987) 1219-1223
43. Robinson T.E., and Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 18 (1993) 247-291
44. Safer D.J., Zito J.M., and Fine E.M. Increased methylphenidate usage for attention deficit disorder in the 1990s. Pediatrics 98 (1996) 1084-1088
45. Schenk S., and Izenwasser S. Pretreatment with methylphenidate sensitizes rats to the reinforcing effects of cociane. Pharmacol Biochem Behav 72 (2002) 651-657
46. Schultz W. Getting formal with dopamine and reward. Neuron 36 (2002) 241-263
47. Seeman P., and Madras B. Methylphenidate elevates resting dopamine which lowers the impulse-triggered release of dopamine: a hypothesis. Behav Brain Res 130 (2002) 79-83
48. Segal D.S., and Mandell A.J. Long-term administration of d-amphetamine: progressive augmentation of motor activity and stereotypy. Pharmacol Biochem Behav 2 (1974) 249-255
49. Self D. Neurobiology: Dopamine as chicken and egg. Nature 422 (2003) 573-574
50. Shader R.I., Harmatz J.S., Oesterheld J.R., Parmelee D.X., Sallee F.R., and Greenblatt D.J. Population pharmacokinetics of methylphenidate in children with attention-deficit hyperactivity disorder. J Clin Pharmacol 39 (1999) 775-785
51. Spear L.P. The adolescent brain and age-related behavioral manifestations. Neurosci Biobehav Rev 24 (2000) 417-463
52. Swanson J.M., Sergeant J.A., Taylor E., Sonuga-Barke E.J., Jensen P.S., and Cantwell D.P. Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet 351 (1998) 429-433
53. Swanson J.M., and Volkow N.D. Pharmacokinetic and pharmacodynamic properties of stimulants: implications for the design of new treatments for ADHD. Behav Brain Res 130 (2002) 73-78
54. Tanaka E. Gender-related differences in pharmacokinetics and their clinical significance. J Clin Pharm Ther 24 (1999) 339-346
55. Tang K., Low M.J., Grandy D.K., and Lovinger D.M. Dopamine-dependent synaptic plasticity in striatum during in vivo development. Proc Natl Acad Sci U S A 98 (2001) 1255-1260
56. Torres-Reveron A., and Dow-Edwards D.L. Repeated administration if methylphenidate in young, adolescent, and mature rats affects the response to cocaine later in adulthood. Psychopharmacology 181 (2005) 38-47
57. Uhl G. Neurochemical Bases of Drug Abuse. In: Siegel J.S., Albers R.W., Fisher S.K., and Uhler M.D. (Eds). Basic Neurochemistry: Molecular, Cellular and Medical Aspects (1999), Lippincott-Raven, Philadelphia 1095-1107 AB
58. Vastag B. Pay attention: ritalin acts much like cocaine. JAMA 286 (2001) 905-906
59. Volkow N.D., Ding Y.S., Fowler J.S., Wang G.J., Logan J., Gatley J.S., et al. Is methylphenidate like cocaine?. Studies on their pharmacokinetics and distribution in the human brain. Arch Gen Psychiatry 52 (1995) 456-463
60. Volkow N.D., Gatley S.J., Fowler J.S., Wang G.J., and Swanson J. Serotonin and the therapeutic effects of ritalin. Science 288 (2000) 11
61. Volkow N.D., and Insel T.R. What are the long-term effects of methylphenidate treatment?. Biol Psychiatry 54 (2003) 1307-1309
62. Volkow N.D., Wang G.J., Fowler J.S., Gatley S.J., Ding Y.S., Logan J., et al. Relationship between psychostimulant-induced "high" and dopamine transporter occupancy. Proc Natl Acad Sci U S A 93 (1996) 10388-10392
63. Volkow N.D., Wang G.J., Fowler J.S., Gatley S.J., Logan J., Ding Y.S., et al. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am J Psychiatry 155 (1998) 1325-1331
64. Volkow N.D., Wang G.J., Fowler J.S., Gatley S.J., Logan J., Ding Y.S., et al. Blockade of striatal dopamine transporters by intravenous methylphenidate is not sufficient to induce self-reports of "high". J Pharmacol Exp Ther 288 (1999) 14-20
65. Wang G., Volkow N.D., Hitzemann R.J., Wong C., Angrist B., Burr G., Pascani K., Pappas N., Lu A., Cooper T., and Lieberman J.A. Behavioral and cardiovascular effects of intravenous methylphenidate in normal subjects and cocaine abusers. European Addiction Research 3 (1997) 49-54
66. White F.J., and Kalivas P.W. Neuroadaptations involved in amphetamine and cocaine addiction. Drug Alcohol Depend 51 (1998) 141-153
67. Williams J.S., and Zickler P. Researcher's Probe for Clues to ADHD Medications' Protective Effects. NIDA Notes 18 (2003) 11-13
68. Wise R.A., and Bozarth M.A. A psychomotor stimulant theory of addiction. Psychol Rev 94 (1987) 469-492
69. Wolf M.E. The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog Neurobiol 54 (1998) 679-720
70. Wolf M.E., Sun X., Mangiavacchi S., and Chao S.Z. Psychomotor stimulants and neuronal plasticity. Neuropharmacology 47 Suppl 1 (2004) 61-79
71. Yang P.B., Swann A.C., and Dafny N. Chronic pretreatment with methylphenidate induces cross-sensitization with amphetamine. Life Sci 73 (2003) 2899-2911
72. Zito J.M., Safer D.J., dosReis S., Gardner J.F., Boles M., and Lynch F. Trends in the prescribing of psychotropic medications to preschoolers. JAMA 283 (2000) 1025-1030